An interventional study of intensive screening in Hodgkin Disease and Breast Cancer, sponsored by Institut Paoli-Calmettes. Terminated at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-14.
Sponsored by Institut Paoli-Calmettes · Not applicable, Interventional, and Prevention
After treatment for Hodgkin disease, secondary cancer, in particular breast cancer induced by treatment, are the first cause of death.
The investigators will estimate the risk to develop breast cancer in this population of women treated for hodgkin disease, and will propose women at high rish to participate in an intensive screening program based on an annual detection based on mammography, echography, and RMI.
914 studies on the registry are indexed under Hodgkin Disease; 136 are open to participants now.
This study's enrollment of 51 is above the median of 43 across 746 interventional studies indexed under Hodgkin Disease.
Browse Hodgkin Disease studies →Institut Paoli-Calmettes is the lead sponsor of 172 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
annual breast cancer detection based on mammography, echography and RMI.
Procedure: intensive screening
Each year, women will have breast cancer detection based on mammography, echography and RMI. Questionaries will also be completed.
efficacy of the screening
The efficacy of the screening will be evaluated by the rate of early stage breast cancer detected. The rate of in situ, \< 10 mm(T1b), and N0 will be estimated.
Time frame: 15 years
interest
The rate of interest is the % of women at high risk who will accept the intensive screening
Time frame: 1 month
adhesion
The adhesion rate is the % of women who will effectively undergo the first screnning among the women who had accepted their participation in this intensive screening
Time frame: 1 month
compliance
The compliance will be evaluated yearly. The number of exam realised compared to the theoric number and the time between 2 exams will be estimated.
Time frame: 15 years
psychologic impact
The psychologic impact will be assessed yearly by questionnaries evaluating quality of life, anxiety and satisfaction.
Time frame: 15 years
This study is terminated, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.